Skip to main content
Premium Trial:

Request an Annual Quote

Tempus: Joel Dudley

Joel Dudley has joined Tempus as senior vice president of research, in charge of all non-oncology R&D efforts for the company, which is in the midst of expanding from its original focus on cancer into cardiology and depression. Dudley previously was executive VP for precision health at Mount Sinai Health System and founding director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai. 

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.